MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease
Samir R. Nath, Matthew Lieberman, Zhigang Yu, Caterina Marchioretti, Samuel T. Jones, Emily C. E. Danby, Kate M. Van Pelt, Gianni Sorarú, Diane M. Robins, Gillian P. Bates, Maria Pennuto, Andrew P. Lieberman
Topics & Concepts
Spinal and bulbar muscular atrophyMef2BiologyProteotoxicityMuscle atrophyAtrophySkeletal muscleMyocyteCell biologyAndrogen receptorEndocrinologyGene expressionGeneticsEnhancerGeneProtein aggregationProstate cancerCancerGenetic Neurodegenerative DiseasesMuscle Physiology and DisordersNeurogenetic and Muscular Disorders Research